These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35060345)
1. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis. Zheng L; Feng Z; Tao S; Gao J; Lin Y; Wei X; Zheng B; Huang B; Zheng Z; Zhang X; Liu J; Shan Z; Chen Y; Chen J; Zhao F Clin Transl Med; 2022 Jan; 12(1):e652. PubMed ID: 35060345 [TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway. Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559 [TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway. Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331 [TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme. Lee SH; Kwon HJ; Park S; Kim CI; Ryu H; Kim SS; Park JB; Kwon JT PLoS One; 2021; 16(9):e0257375. PubMed ID: 34516577 [TBL] [Abstract][Full Text] [Related]
6. Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathway. Jin K; Zheng L; Ye L; Xie Z; Gao J; Lou C; Pan W; Pan B; Liu S; Chen Z; He D Biochem Pharmacol; 2021 Oct; 192():114734. PubMed ID: 34411569 [TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity. Kim MJ; Kim WS; Kim DO; Byun JE; Huy H; Lee SY; Song HY; Park YJ; Kim TD; Yoon SR; Choi EJ; Ha H; Jung H; Choi I Cell Signal; 2017 Jun; 34():110-120. PubMed ID: 28323005 [TBL] [Abstract][Full Text] [Related]
8. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702 [TBL] [Abstract][Full Text] [Related]
9. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Winner M; Meier J; Zierow S; Rendon BE; Crichlow GV; Riggs R; Bucala R; Leng L; Smith N; Lolis E; Trent JO; Mitchell RA Cancer Res; 2008 Sep; 68(18):7253-7. PubMed ID: 18794110 [TBL] [Abstract][Full Text] [Related]
10. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling. Wang XZ; Zhang SF; Yang ZH; Ye ZW; Liu J J Biol Regul Homeost Agents; 2020; 34(5):1699-1708. PubMed ID: 33148374 [TBL] [Abstract][Full Text] [Related]
11. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway. Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772 [TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. De R; Sarkar S; Mazumder S; Debsharma S; Siddiqui AA; Saha SJ; Banerjee C; Nag S; Saha D; Pramanik S; Bandyopadhyay U J Biol Chem; 2018 Dec; 293(51):19740-19760. PubMed ID: 30366984 [TBL] [Abstract][Full Text] [Related]
13. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas. Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776 [TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis. Gu R; Santos LL; Ngo D; Fan H; Singh PP; Fingerle-Rowson G; Bucala R; Xu J; Quinn JM; Morand EF Cytokine; 2015 Apr; 72(2):135-45. PubMed ID: 25647268 [TBL] [Abstract][Full Text] [Related]
15. Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway. Liao D; Zhong L; Duan T; Zhang RH; Wang X; Wang G; Hu K; Lv X; Kang T Clin Cancer Res; 2015 Dec; 21(23):5349-59. PubMed ID: 26202947 [TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury. Zhou Y; Guo W; Zhu Z; Hu Y; Wang Y; Zhang X; Wang W; Du N; Song T; Yang K; Guan Z; Wang Y; Guo A J Neuroinflammation; 2018 Sep; 15(1):253. PubMed ID: 30180853 [TBL] [Abstract][Full Text] [Related]
17. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass. Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992 [TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease. Lv J; Huang XR; Klug J; Fröhlich S; Lacher P; Xu A; Meinhardt A; Lan HY Clin Sci (Lond); 2013 May; 124(10):627-37. PubMed ID: 23252627 [TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608 [TBL] [Abstract][Full Text] [Related]
20. Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo. Hussain F; Freissmuth M; Völkel D; Thiele M; Douillard P; Antoine G; Thurner P; Ehrlich H; Schwarz HP; Scheiflinger F; Kerschbaumer RJ Mol Cancer Ther; 2013 Jul; 12(7):1223-34. PubMed ID: 23619302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]